论文部分内容阅读
鳞状细胞癌抗原(squamous cell carci-noma antigen,SCC-Ag)是宫颈、肺、食管及头颈等部位癌的肿瘤标志物。但对喉癌尚未进行过SCC-Ag的特定研究。本研究试图评价SCC-Ag在喉癌诊断治疗中的作用。 研究对象为喉癌患者168例及60名健康供血者(对照组)。喉癌患者平均年龄为59±9. 6岁。用ABBOT SCC酶免疫分析法测定SCC-Ag。对113例经手术治疗的病人分别在术后24小时和1周后测定,术后放疗完
Squamous cell carcinia antigen (SCC-Ag) is a tumor marker of cancer of the cervix, lung, esophagus and head and neck. However, no specific study of SCC-Ag has been performed on laryngeal cancer. This study attempted to evaluate the role of SCC-Ag in the diagnosis and treatment of laryngeal cancer. The subjects were 168 laryngeal cancer patients and 60 healthy donors (control group). The average age of laryngeal cancer patients was 59 ± 9. 6 years old. SCC-Ag was measured by ABBOT SCC enzyme immunoassay. 113 cases of patients after surgery were measured at 24 hours and 1 week after surgery, after radiotherapy